OBJECTIVE. The objective of our study was to show the efficacy and safety of percutaneous ethanol ablation in managing recurrent primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1 (MEN1) after subtotal parathyroidectomy. CONCLUSION. Ethanol ablation is a viable alternative to reoperation for the management of recurrent primary hyperparathyroidism in patients with MEN1.
- Alcohol ablation
- Ethanol ablation
- Multiple endocrine neoplasia syndrome
- Parathyroid gland
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging